Sam Evans
Founding Partner @ Eos Venture Partners
London, United Kingdom
Sam Evans is a seed investor at Eos Venture Partners in London focused on Finance and Medical. Sam Cavell Evans is based out of London and is the founding partner of Eos Venture Partners. Sam previously worked at KPMG UK as a partner.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Sam Evans invests in
Stages Sam Evans invests in
Countries Sam Evans invests in
Investment Focus
Industry
- Finance 1 (25%)
- Medical 1 (25%)
- Wellness 1 (25%)
- Insurance 1 (25%)
- Health Care 1 (25%)
Stage
- Seed 1 (25%)
- Series A 1 (25%)
- Series B 1 (25%)
- Funding Round 1 (25%)
Country
- United States 1 (25%)
- United Arab Emirates 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Fountain Life
|
Fountain Life delivers AI-powered diagnostics, multi-modal imaging, genetic analysis, and personalized health plans designed to support longevity and proactive disease prevention. It integrates functional-medicine protocols with comprehensive “Upload” diagnostics, blood, imaging, and genomics, to detect early signs of illness and guide tailoredhealth optimization. Members engage with a care team that includes physicians, coaches, and nutritionists to translate diagnostic insights into individualized longevity and wellness strategies. | $18M / Series B / Aug 13, 2025 | |
|
Fountain Life
|
Fountain Life delivers AI-powered diagnostics, multi-modal imaging, genetic analysis, and personalized health plans designed to support longevity and proactive disease prevention. It integrates functional-medicine protocols with comprehensive “Upload” diagnostics, blood, imaging, and genomics, to detect early signs of illness and guide tailoredhealth optimization. Members engage with a care team that includes physicians, coaches, and nutritionists to translate diagnostic insights into individualized longevity and wellness strategies. | $15M / Dec 15, 2022 | |
|
Fountain Life
|
Fountain Life delivers AI-powered diagnostics, multi-modal imaging, genetic analysis, and personalized health plans designed to support longevity and proactive disease prevention. It integrates functional-medicine protocols with comprehensive “Upload” diagnostics, blood, imaging, and genomics, to detect early signs of illness and guide tailoredhealth optimization. Members engage with a care team that includes physicians, coaches, and nutritionists to translate diagnostic insights into individualized longevity and wellness strategies. | $15M / Series A / Dec 15, 2022 | |
Democrance
|
An insurance technology company with a mission to create partnerships that make insurance accessible for those who need it most but can afford it least. | $800K / Seed / Oct 22, 2017 |
Co-Investors
About Eos Venture Partners
Eos Venture Partners is a Strategic Venture Capital Fund focused on insurance. Eos invests in early and growth stage insurance technology businesses whilst working closely with our Limited Partners to accelerate their innovation strategy.
Eos Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
James Tootell
Investment Director
|
|||
|
Sam Evans
Founding Partner
|
|||
Stephen McGovern
Senior Associate
|
|||
Stephen McGovern
Senior Associate
|
|||
Carl Bauer
Founding Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Sam Evans invest in?
Sam Evans invests primarily in Finance, Medical and Wellness startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Sam Evans last invest?
The most recent investment recorded for Sam Evans closed in Aug 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
